Crimean hemorrhagic fever in a COVID-19 patient: a clinical case

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Crimean hemorrhagic fever (CHF) is endemic in the southern regions of the Republic of Kazakhstan. During the COVID-19 pandemic, there are cases of CHF and COVID-19 coinfection, presenting substantial difficulties in both the diagnosis and treatment of these patients. CHF cases and outbreaks are an additional threat during the pandemic due to the severity of the course, the difficulty of differential diagnosis, and the poor prognosis of CHF and COVID-19. The 2020-2021 summer as the most active season for the incidence of CHF in the city of Shymkent and the Turkestan Region coincided with the peaks in the waves of the COVID-19 pandemic, whereas the similarity of the symptoms of the diseases involved difficulties in establishing a diagnosis. The paper describes clinical case of a patient with severe CHF in the presence of clinical signs of coronavirus infection, COVID-19-associated pneumonia, with a favorable outcome, who has been treated in the Shymkent City Infectious Diseases Hospital. Timely diagnosis and etiotropic therapy with ribavirin, replacement treatment with blood drugs and the use of immunized convalescent plasma could achieve a favorable outcome.

Full Text

Restricted Access

About the authors

Guldzhan N. Abuova

South Kazakhstan Medical Academy

Email: dr.abuova@gmail.com
Can. Med. Sci., Head, Department of Infectious Diseases and Dermatovenerology

Natalia Yu. Pshenichnaya

Central Research Institute of Epidemiology

Email: natalia-pshenichnaya@yandex.ru
MD, Deputy Director for Clinical and Analytical Work

Farida A. Berdalieva

South Kazakhstan Medical Academy

Email: fberdalieva@mail.ru
Can. Med. Sci., Associate Professor, Department of Infectious Diseases and Dermatovenerology

Tatiana V. Polukchi

South Kazakhstan Medical Academy

Email: tatyana_polukchi@mail.ru
Assistant Lecturer, Department of Infectious Diseases and Dermatovenerology

Daulet S. Aliev

South Kazakhstan Medical Academy

Email: dauletaliev68@mail.ru
Assistant Lecturer, Department of Infectious Diseases and Dermatovenerology

Dana K. Sadykhova

South Kazakhstan Medical Academy

Email: danoka.kz@mail.ru
Assistant Lecturer, Department of Infectious Diseases and Dermatovenerology

Eldar Yu. Aliev

Shymkent City Infectious Diseases Hospital

Email: eldar_aliev_84@inbox.ru
Highest-Category Resuscitator

Irina A. Lizinfeld

Central Research Institute of Epidemiology

Email: irinalizinfeld@gmail.com
Advisor

Vasily G. Akimkin

Central Research Institute of Epidemiology

Academician of the Russian Academy of Sciences, MD, Director

References

  1. Fletcher T.E., Abuova G., Ahmeti S., Al-Abri S.S., Asik Z., Atilla A. et al. Infection prevention and control practice for Crimean-Congo hemorrhagic fever-A multi-center crosssectional survey in Eurasia. PLoS One 2017; 12(9): e0182315. doi: 10.1371/journal.pone.0182315. PMID: 28886039; PMCID: PMC5590734
  2. BUyUktuna S., Hasbek M., Oksuz C., Baysal C., Oz M., Elaldi N. et al. Kirim Kongo Kanamali Ate§i Hastasinda COVID-19 Ko-enfeksiyonu: Bir Olgu Sunumu [COVID-19 Co-infection in a patient with Crimean Congo Hemorrhagic Fever: A Case Report]. Mikrobiol. Bul. 2021; 55(3): 445-51. (Turkish). doi: 10.5578/mb.20219813. PMID: 34416809
  3. Butt M.H., Ahmad A., Misbah S., Mallhi T.H., Khan Y.H. Crimean-Congo hemorrhagic fever and Eid-Ul-Adha: A potential threat during the COVID-19 pandemic. J. Med. Virol. 2021; 93(2): 618-9. doi: 10.1002/jmv.26388. PMID: 32749713; PMCID: PMC7436305
  4. Pazarli A.C., Parlak Z., Ekiz T. COVID-19 and Crimean-Congo Hemorrhagic Fever: Similarities and Differences. Heart Lung. 2020; 49(6): 892-3. doi: 10.1016/j.hrtlng.2020.05.013. PMID: 32536567; PMCID: PMC7266772
  5. Ozaras R., Dilek A., Sunbul M., Leblebicioglu H. Association between Crimean-Congo hemorrhagic fever (CCHF) and coronavirus disease 2019 (COVID-19): A systematic review. Infect. Control Hosp. Epidemiol. 2021; 12. doi: 10.1017/ice.2021.388. PMID: 34462024; PMCID: PMC8438420
  6. Dulger A.C., Yakari§ik M., Uzun Y.E., §ahin A.M. Treatment of Crimean-Congo Haemorrhagic Fever by Favipiravir in a Patient with Novel Coronavirus Co-Infection. Eur. J. Case Rep. Int. Med. 2020; 7(12): 002042. doi: 10.12890/2020_002042. PMID: 33457366; PMCID: PMC7806293
  7. Albayrak A., Alay H., Yilmaz S.I. Comorbidity of Crimean-Congo Hemorrhagic Fever and COVID-19. Rev. Soc. Bras. Med. Trop. 2021; 54: e0429. doi: 10.1590/0037-8682-0429 2021. PMID: 34586291; PMCID: PMC8463030

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2022 Bionika Media